NEOPLASMS, HEAD AND NECK
Clinical trials for NEOPLASMS, HEAD AND NECK explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, HEAD AND NECK trials appear
Sign up with your email to follow new studies for NEOPLASMS, HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to supercharge immune system against HPV cancer
Disease control CompletedThis study tested whether adding a new immunotherapy called PDS0101 to an existing drug (pembrolizumab) could better treat advanced head and neck cancer caused by HPV16. It involved 95 adults whose cancer had returned or spread. The goal was to see if the combination could help t…
Matched conditions: NEOPLASMS, HEAD AND NECK
Phase: PHASE2 • Sponsor: PDS Biotechnology Corp. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Drug trial aims to stop Cancer's return after surgery
Disease control CompletedThis study tested whether adding the immunotherapy drug pembrolizumab (MK-3475) to standard surgery could better control advanced head and neck cancer. It involved 67 high-risk patients with stage III or IV cancer that could be surgically removed. Researchers aimed to see if the …
Matched conditions: NEOPLASMS, HEAD AND NECK
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC